Tubeless automated insulin delivery system improves blood glucose outcomes

(The Endocrine Society) People with type 1 diabetes can improve their blood sugar control while reducing time with low blood sugar, or hypoglycemia, using Insulet Corporation's Omnipod 5 Automated Insulin Delivery System compared to their standard insulin therapy. Results from an industry-sponsored study of the latest Omnipod, the first tubeless, wearable insulin pump, will be presented at ENDO 2021, the Endocrine Society's annual meeting.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news